<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arises in the backdrop of Barrett <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> sequence, with the vast majority of patients presenting with late-stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Mesothelin, a glycophosphatidylinositol-anchored protein, is aberrantly overexpressed on the surface of many solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Mesothelin expression was assessed in esophageal tissue microarrays encompassing the entire histological spectrum of Barrett-associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Mesothelin expression was observed in 24/84 (29%) of invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and in 5/34 (15%) <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, <z:mpath ids='MPATH_458'>normal</z:mpath> squamous and cardiac mucosa, as well as noninvasive Barrett lesions, failed to label with mesothelin </plain></SENT>
<SENT sid="5" pm="."><plain>Mesothelin was expressed in the esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell line JH-EsoAd1 but not in primary human esophageal epithelial cells </plain></SENT>
<SENT sid="6" pm="."><plain>Anti-mesothelin antibody-conjugated <z:chebi fb="0" ids="50834">CdSe</z:chebi>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CDS</z:e>/ZnS quantum rods were synthesized, and confocal bioimaging confirmed robust binding to JH-EsoAd1 cells </plain></SENT>
<SENT sid="7" pm="."><plain>Anti-mesothelin antibody-conjugated nanoparticles can be useful for the diagnosis and therapy of mesothelin-overexpressing esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
</text></document>